Antimicrobial agents and chemotherapy

• 

  Año 2005, Vol. 49, Número 1

  • Vancomycin Resistance in Enterococci Due to Synthesis of Precursors Terminating in D-Alanyl-D-Serine

    P. E. Reynolds

    págs. 21-25

    

  • Virulence Genotype and Phylogenetic Origin in Relation to Antibiotic Resistance Profile among Escherichia coli Urine Sample Isolates from Israeli Women with Acute Uncomplicated Cystitis

    M. A. Kuskowski, J. R. Johnson

    págs. 26-31

    

  • Differences in the Enterococcus faecalis lsa Locus That Influence Susceptibility to Quinupristin-Dalfopristin and Clindamycin

    B. E. Murray, Kavindra V. Singh

    págs. 32-39

    

  • Glycine-Amide Is an Active Metabolite of the Antiretroviral Tripeptide Glycyl-Prolyl-Glycine-Amide

    E. Andersson

    págs. 40-44

    

  • In Vitro and In Vivo Synergistic Activities of Linezolid Combined with Subinhibitory Concentrations of Imipenem against Methicillin-Resistant Staphylococcus aureus

    C. Jacqueline

    págs. 45-51

    

  • Antifungal Activities of R-135853, a Sordarin Derivative, in Experimental Candidiasis in Mice

    T. Shibayama, M. Kakuta, Y. Kamai

    págs. 52-56

    

  • Surface-Active Fungicidal D-Peptide Inhibitors of the Plasma Membrane Proton Pump That Block Azole Resistance

    B. C. Monk

    págs. 57-70

    

  • Emergence of Plasmid-Mediated Quinolone Resistance in Escherichia coli in Europe

    M. van de Loo, H. Mammeri

    págs. 71-76

    

  • Comparison of Three PCR Primer Sets for Identification of vanB Gene Carriage in Feces and Correlation with Carriage of Vancomycin-Resistant Enterococci: Interference by vanB-Containing Anaerobic Bacilli

    P. D. R. Johnson, E. A. Grabsch, S. A. Ballard

    págs. 77-81

    

  • Recommendation of an Appropriate Medium for In Vitro Drug Susceptibility Testing of the Fish Pathogen Tenacibaculum maritimum

    Rubén E. Avendaño-Herrera

    págs. 82-87

    

  • Effect of Antibiotics on Group A Streptococcus Exoprotein Production Analyzed by Two-Dimensional Gel Electrophoresis

    M. Tanaka, T. Hasegawa

    págs. 88-96

    

  • Distribution of Antimicrobial Resistance and Virulence-Related Genes among Brazilian Group B Streptococci Recovered from Bovine and Human Sources

    M. A. V. P. Brito, O. P. Miranda, B. C. Bellei, R. S. Duarte

    págs. 97-103

    

  • Clonal Relatedness and Conserved Integron Structures in Epidemiologically Unrelated Pseudomonas aeruginosa Strains Producing the VIM-1 Metallo-beta-Lactamase from Different Italian Hospitals

    M. L. Riccio, L. Pallecchi, J.D. Docquier

    págs. 104-110

    

  • Removal of Group B Streptococci Colonizing the Vagina and Oropharynx of Mice with a Bacteriophage Lytic Enzyme

    D. Nelson, Q. Cheng

    págs. 111-117

    

  • Interaction of the Plasmid-Encoded Quinolone Resistance Protein Qnr with Escherichia coli DNA Gyrase

    D. C. Hooper, J. H. Tran, G. A. Jacoby

    págs. 118-125

    

  • Buthionine Sulfoximine Increases the Toxicity of Nifurtimox and Benznidazole to Trypanosoma cruzi

    M. Faundez

    págs. 126-130

    

  • Identification of Novel Inhibitors of Bacterial Translation Elongation Factors

    M. M. K. Jayasekera

    págs. 131-136

    

  • Emergence and Spread of Neisseria gonorrhoeae Clinical Isolates Harboring Mosaic-Like Structure of Penicillin-Binding Protein 2 in Central Japan

    K. S. Mizutani, T. Deguchi, M. Ito

    págs. 137-143

    

  • New Multiplex PCR for Rapid Detection of Isoniazid-Resistant Mycobacterium tuberculosis Clinical Isolates

    L. Herrera Leon

    págs. 144-147

    

  • Pharmacokinetics of Oritavancin in Plasma and Skin Blister Fluid following Administration of a 200-Milligram Dose for 3 Days or a Single 800-Milligram Dose

    G. J. Fetterly

    págs. 148-152

    

  • Efficacy and Safety of Pharmacokinetically Enhanced Amoxicillin-Clavulanate at 2,000/125 Milligrams Twice Daily for 5 Days versus Amoxicillin-Clavulanate at 875/125 Milligrams Twice Daily for 7 Days in the Treatment of Acute Exacerbations of Chronic Bronchitis

    J. Breton, S. Sethi

    págs. 153-160

    

  • Effect of Promoter Region Mutations and mgrA Overexpression on Transcription of norA, Which Encodes a Staphylococcus aureus Multidrug Efflux Transporter

    G. W. Kaatz, R. V. Thyagarajan

    págs. 161-169

    

  • Ecological Effects of Perorally Administered Pivmecillinam on the Normal Vaginal Microflora

    A. Fianu Jonasson, A. Sullivan

    págs. 170-175

    

  • Antileishmanial Activity of Parthenolide, a Sesquiterpene Lactone Isolated from Tanacetum parthenium

    T. S. Tiuman, T. Ueda-Nakamura

    págs. 176-182

    

  • Induction of beta-Defensin Resistance in the Oral Anaerobe Porphyromonas gingivalis

    C. E. Shelburne

    págs. 183-187

    

  • Pharmacodynamic Profile of Telithromycin against Macrolide- and Fluoroquinolone-Resistant Streptococcus pneumoniae in a Neutropenic Mouse Thigh Model

    C. H. Nightingale, P. K. Dandekar, H. M. Mattoes, P. R. Tessier

    págs. 188-194

    

  • Pharmacokinetics, Serum Inhibitory and Bactericidal Activity, and Safety of Telavancin in Healthy Subjects

    J. P. Shaw, J. Seroogy

    págs. 195-201

    

  • OXA-58, a Novel Class D beta-Lactamase Involved in Resistance to Carbapenems in Acinetobacter baumannii

    S. Marque, L. Poirel, C. Heritier

    págs. 202-208

    

  • Pharmacodynamic Modeling of Ciprofloxacin Resistance in Staphylococcus aureus

    P. J. McNamara, J. J. Campion

    págs. 209-219

    

  • Pharmacokinetics of Tigecycline after Single and Multiple Doses in Healthy Subjects

    G. Muralidharan

    págs. 220-229